Zobair M. Younossi, MD, MPH
Articles by Zobair M. Younossi, MD, MPH
Service Line Care Delivery Model for COVID-19 Patient-Centric Care
ByAshiq Mannan, MD,Nick Sutingco, MD,Svet Djurkovic, MD,Mary Reyes, MD,Mehul Desai, MD,Soleyah Groves, MD,Ivan Garcia, MD,Wali Azizi, MD,Andrew Miner, MD,Sam Elgawly, MD,Greg Trimble, MD,Paul Weisbruch, MD,Erik Osborn, MD,Steven Dean, MD,Maruf Haider, MD,Madeline Erario, MD,Patricia Horgas, MSN,Erin Hodson, MSN,Brian Lam, PA,Jennifer Bautista, MD,Andrei Racila, BS,Andrej Kolacevski, PhD,Linda Henry, PhD,Stephen Motew, MD,Chapy Venkatesan, MD,Ann Huston, MHS,Naomi Lynn Gerber, MD,J. Stephen Jones, MD,Zobair M. Younossi, MD, MPH The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.
Outcomes of Liver Transplantation by Insurance Type in the United States
ByMaria Stepanova, PhD,Saleh Al Qahtani, MD,Alita Mishra, MD,Issah Younossi, MPH,Chapy Venkatesan, MD,Zobair M. Younossi, MD, MPH Patients with publicly sponsored insurance who were listed for liver transplantation have worse wait-list and posttransplant outcomes, as shown using the US Scientific Registry of Transplant Recipients (2001-2017).
Impact of Hepatitis C Virus and Insurance Coverage on Mortality
ByHaley Bush, MSPH,James Paik, PhD,Pegah Golabi, MD,Leyla de Avila, BA,Carey Escheik, BS,Zobair M. Younossi, MD, MPH The Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.
